51 related articles for article (PubMed ID: 23662599)
1. Single-dose nonsteroidal anti-inflammatory drugs in horses have no impact on concentrations of cytokines or growth factors in autologous protein solution and platelet-rich plasma.
Brown KA; Gregorio EN; Barot D; Usimaki A; Linardi RL; Missanelli JR; You Y; Robinson MA; Ortved KF
Am J Vet Res; 2024 Apr; 85(4):. PubMed ID: 38346393
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of oral phenylbutazone and firocoxib in horses has no impact on selected cytokine and growth factor concentrations in platelet-rich plasma and autologous protein solution.
Brown KA; Gregorio EN; Barot D; Usimaki A; Linardi RL; Missanelli JR; You Y; Robinson MA; Ortved KF
Am J Vet Res; 2024 Jun; ():1-8. PubMed ID: 38889765
[TBL] [Abstract][Full Text] [Related]
3. Hematological and Biochemical Effects Associated with Prolonged Administration of the NSAID Firocoxib in Adult Healthy Horses.
Ignácio FS; Garcia LV; de Souza GG; Amatti LZ; de Barros LD; Bergfelt DR; Camargo GS; de Meira C; de Almeida BFM
Vet Sci; 2024 Jun; 11(6):. PubMed ID: 38922003
[TBL] [Abstract][Full Text] [Related]
4. Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses.
Araújo RA; Sales NAA; Basile RC; Feringer-Junior WH; Apparício M; Ferraz GC; Queiroz-Neto A
Vet Sci; 2023 Aug; 10(9):. PubMed ID: 37756053
[TBL] [Abstract][Full Text] [Related]
5. Is firocoxib as effective as flunixin meglumine in providing postoperative analgesia in horses following colic surgery?
Keen A; Shipman E
Vet Rec; 2024 Feb; 194(3):115-116. PubMed ID: 38305529
[No Abstract] [Full Text] [Related]
6. Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses.
White JM; Colbath AC; Schott HC
J Vet Intern Med; 2023; 37(6):2544-2551. PubMed ID: 37882246
[TBL] [Abstract][Full Text] [Related]
7. [New drugs for small animals in 2023].
Emmerich IU
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2024 Apr; 52(2):110-116. PubMed ID: 38701806
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Interventions to Immunologic and Immune-Mediated Conditions in Horses.
Hart KA; Kimura S
Vet Clin North Am Equine Pract; 2024 Jun; ():. PubMed ID: 38852015
[TBL] [Abstract][Full Text] [Related]
9. Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses.
Knych HK; Stanley SD; Arthur RM; Mitchell MM
Equine Vet J; 2014 Nov; 46(6):734-8. PubMed ID: 24393414
[TBL] [Abstract][Full Text] [Related]
10. Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses.
Fadel C; Giorgi M
Vet Anim Sci; 2023 Mar; 19():100286. PubMed ID: 36684818
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Nociceptive Effects of Buprenorphine, Firocoxib, and Meloxicam in a Plantar Incision Model in Sprague-Dawley Rats.
Bennett TE; Pavek TJ; Schwark WS; Singh B
J Am Assoc Lab Anim Sci; 2021 Sep; 60(5):539-548. PubMed ID: 34266519
[TBL] [Abstract][Full Text] [Related]
12. Use of firocoxib for the treatment of equine osteoarthritis.
Donnell JR; Frisbie DD
Vet Med (Auckl); 2014; 5():159-168. PubMed ID: 32670856
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.
Barton MH; Paske E; Norton N; King D; Giguère S; Budsberg S
Equine Vet J; 2014 Jan; 46(1):72-5. PubMed ID: 23662599
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
Holland B; Fogle C; Blikslager AT; Curling A; Barlow BM; Schirmer J; Davis JL
J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
[TBL] [Abstract][Full Text] [Related]
15. Effect of firocoxib on cyclooxygenase 2, microsomal prostaglandin E2 synthase 1, and cytosolic phospholipase A2 gene expression in equine mononuclear cells.
Barton MH; Darden JE; Clifton S; Vandenplas M
Am J Vet Res; 2015 Dec; 76(12):1051-7. PubMed ID: 26618729
[TBL] [Abstract][Full Text] [Related]
16. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
Goodman LA; Torres BT; Reynolds LR; Budsberg SC
Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Regulation in the USA and Pharmacokinetics Parameters of Firocoxib, a Highly Selective Cox-2, by Pain Management in Horses.
Rangel-Nava A; Ramírez-Uribe JM; Recillas-Morales S; Ibancovichi-Camarillo JA; Venebra-Muñoz A; Sánchez-Aparicio P
J Equine Vet Sci; 2019 Jun; 77():36-42. PubMed ID: 31133314
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
